Cancer Epidemiology Biomarkers & Prevention, Vol 6, Issue 7 499-504, Copyright © 1997 by American Association for Cancer Research

ARTICLES

p53 mutations in head and neck cancer: new data and evaluation of mutational spectra

AF Olshan, MC Weissler, H Pei and K Conway
Department of Epidemiology, School of Public Health, University of North Carolina, Chapel Hill 27599, USA. andy_olshan@unc.edu

It has been suggested that the frequency, type, and location of p53 mutations (mutational spectra) can be linked to specific exogenous and endogenous carcinogenic agents and processes. Squamous cell carcinoma of the head and neck (SCCHN) provides an excellent tumor model to evaluate the utility of the p53 mutational spectra, given that it has well-defined and strong risk factors (tobacco and alcohol). The purpose of this analysis was to establish the pattern of p53 mutations in SCCHN and evaluate this mutational spectrum in comparison to the spectra for other cancers with similar and different risk factors, including cancers of the esophagus, lung, and colon. p53 mutational data were obtained from head and neck tumors collected at the University of North Carolina Hospitals and the published literature. A total of 14 of 33 tumors from the University of North Carolina Hospitals (42%) were found to have a p53 mutation. The alterations included three transversions, seven transitions, two deletions, and two suspected codon 47 polymorphisms. In general, SCCHN and esophageal cancer share a similar mutational pattern in contrast to colon cancer. These two aerodigestive tract cancers were statistically different from lung cancer, despite sharing tobacco as a major risk factor. For example, G-->T transversions, a mutation type considered to be characteristic of exogenous DNA-damaging agents including tobacco smoke carcinogens, varied among tobacco-related cancer sites (14% SCCHN, 11% esophageal, and 31% lung) in contrast to colon cancer (6%). The comparison of mutational spectra for SCCHN and other cancers indicates that the effects of both tobacco and alcohol exposure may yield a pattern of p53 mutations that reflects elements of both exogenous and endogenous exposures.

This article has been cited by other articles:

				W. H. Westra, J. M. Taube, M.L. Poeta, S. Begum, D. Sidransky, and W. M. Koch Inverse Relationship between Human Papillomavirus-16 Infection and Disruptive p53 Gene Mutations in Squamous Cell Carcinoma of the Head and Neck Clin. Cancer Res., January 15, 2008; 14(2): 366 - 369. [Abstract] [Full Text] [PDF]

				M. L. Poeta, J. Manola, M. A. Goldwasser, A. Forastiere, N. Benoit, J. A. Califano, J. A. Ridge, J. Goodwin, D. Kenady, J. Saunders, et al. TP53 Mutations and Survival in Squamous-Cell Carcinoma of the Head and Neck N. Engl. J. Med., December 20, 2007; 357(25): 2552 - 2561. [Abstract] [Full Text] [PDF]

				C. R. Santos, M. Rodriguez-Pinilla, F. M. Vega, J. L. Rodriguez-Peralto, S. Blanco, A. Sevilla, A. Valbuena, T. Hernandez, A. J. van Wijnen, F. Li, et al. VRK1 Signaling Pathway in the Context of the Proliferation Phenotype in Head and Neck Squamous Cell Carcinoma Mol. Cancer Res., March 1, 2006; 4(3): 177 - 185. [Abstract] [Full Text] [PDF]

				R. Schneider-Stock, C. Mawrin, C. Motsch, C. Boltze, B. Peters, R. Hartig, P. Buhtz, A. Giers, A. Rohrbeck, B. Freigang, et al. Retention of the Arginine Allele in Codon 72 of the p53 Gene Correlates with Poor Apoptosis in Head and Neck Cancer Am. J. Pathol., April 1, 2004; 164(4): 1233 - 1241. [Abstract] [Full Text] [PDF]

				D. Ronchetti, C. B. Neglia, B. M. Cesana, N. Carboni, A. Neri, G. Pruneri, and L. Pignataro Association Between p53 Gene Mutations and Tobacco and Alcohol Exposure in Laryngeal Squamous Cell Carcinoma Arch Otolaryngol Head Neck Surg, March 1, 2004; 130(3): 303 - 306. [Abstract] [Full Text] [PDF]

				J. C. Schroeder, K. Conway, Y. Li, K. Mistry, D. A. Bell, and J. A. Taylor p53 Mutations in Bladder Cancer: Evidence for Exogenous versus Endogenous Risk Factors Cancer Res., November 1, 2003; 63(21): 7530 - 7538. [Abstract] [Full Text] [PDF]

				S. A. Geisler, A. F. Olshan, M. C. Weissler, J. Cai, W. K. Funkhouser, J. Smith, and K. Vick p16 and p53 Protein Expression as Prognostic Indicators of Survival and Disease Recurrence from Head and Neck Cancer Clin. Cancer Res., November 1, 2002; 8(11): 3445 - 3453. [Abstract] [Full Text] [PDF]

				E. Okuda, H. Osugi, K. Morimura, N. Takada, M. Takemura, S. Fukushima, M. Higashino, and H. Kinoshita Detection of p53 Gene Mutations in Human Esophageal Squamous Cell Carcinomas Using a p53 Yeast Functional Assay: Possible Difference in Esophageal Carcinogenesis Between the Young and the Elderly Group Clin. Cancer Res., March 1, 2001; 7(3): 600 - 606. [Abstract] [Full Text]

				S. S. Hecht Tobacco Smoke Carcinogens and Lung Cancer J Natl Cancer Inst, July 21, 1999; 91(14): 1194 - 1210. [Abstract] [Full Text] [PDF]